Clopra and Malarone pediatric drug interactions - a phase IV clinical study of FDA data
Summary:
We study 81,434 people who take Clopra (metoclopramide hydrochloride) and Malarone pediatric (atovaquone; proguanil hydrochloride). There is no drug interaction reported.
The study analyzes what interactions people have when they take Clopra and Malarone pediatric. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Clopra?
Clopra has active ingredients of metoclopramide hydrochloride. eHealthMe is studying from 81,430 Clopra users. Check the latest studies of Clopra.
What is Malarone pediatric?
Malarone pediatric has active ingredients of atovaquone; proguanil hydrochloride. eHealthMe is studying from 4 Malarone pediatric users. Check the latest studies of Malarone pediatric.
No report is found.
Do you take Clopra and Malarone pediatric?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Clopra (81,430 reports)
- Malarone pediatric (4 reports)
How the study uses the data?
The study uses data from the FDA. It is based on metoclopramide hydrochloride and atovaquone; proguanil hydrochloride (the active ingredients of Clopra and Malarone pediatric, respectively), and Clopra and Malarone pediatric (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Famvir cause Wound Secretion? - 5 seconds ago
- Ondansetron and Heparin drug interactions for boys aged 2-9 - 6 seconds ago
- Depression in Intuniv, how severe and when it was recovered? - 19 seconds ago
- Amoxicillin and Zaroxolyn drug interactions for women aged 50-59 - 20 seconds ago
- Could Torsemide cause Renal Osteodystrophy? - 25 seconds ago
- Nuvigil and Palpitations Aggravated for Men aged 30-39 - 26 seconds ago
- Nuvigil and Heart Pounding for Men aged 30-39 - 26 seconds ago
- Nuvigil and Heart Racing for Men aged 30-39 - 26 seconds ago
- Nuvigil and Palpitations for Men aged 30-39 - 26 seconds ago
- Nuvigil and Irregular Heartbeat for Men aged 30-39 - 27 seconds ago